Tomeki

FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow

FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow

summary : report to the Congress

By United States. General Accounting Office

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1982

Publisher

U.S. General Accounting Office

Language

eng

Pages

43